Get started
Author

Breven S. Simcox

Observed institution: University of Central Florida
OpenAlex ID: A5014106900
Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors
2021 · Rashmi Gupta, Noora M. S. A. Al-Kharji, et al. · ACS Infectious Diseases · 26
Mycobacterium abscessus DosRS two-component system controls a species-specific regulon required for adaptation to hypoxia
2023 · Breven S. Simcox, Brooke R. Tomlinson, et al. · Frontiers in Cellular and Infection Microbiology · 25
Orphan response regulator NnaR is critical for nitrate and nitrite assimilation in Mycobacterium abscessus
2024 · Breven S. Simcox, Kyle H. Rohde · Frontiers in Cellular and Infection Microbiology · 6
CRISPRi-mediated in vivo gene silencing: a tool for prioritizing drug targets in Mycobacterium abscessus
2026 · Rashmi Gupta, Breven S. Simcox, et al. · Antimicrobial Agents and Chemotherapy · 1
CRISPRi-mediated validation of candidate Mycobacterium abscessus drug targets during host infection
2025 · Rashmi Gupta, Breven S. Simcox, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Works count: 5
Citation count: 58
H-index: 3
I10-index: 2
Year
Topic
Type